
| OPPONENT | AB | R | H | 1B | 2B | 3B | HR | BB | RBI | SO | SAC | SB | AVG | SLG | OB | OPS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mondelez | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | .000 | .000 | .500 | .500 | |
| ASCO | 4 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | .000 | .000 | .000 | .000 | |
| Novartis #2 | 3 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | .333 | .333 | .333 | .667 | |
| Evonik | 3 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 2 | 0 | 1 | 0 | .333 | .333 | .400 | .733 | |
| Mondelez | 4 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | .250 | .500 | .250 | .750 | |
| Pinnacle | 3 | 3 | 2 | 2 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | .667 | .667 | .750 | 1.417 | |
| Celgene #2 | 4 | 2 | 1 | 0 | 0 | 1 | 0 | 1 | 3 | 0 | 0 | 0 | .250 | .750 | .400 | 1.150 | |
| Novartis #1 | 4 | 2 | 2 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | .500 | 1.000 | .500 | 1.500 | |
| TOTAL | 27 | 13 | 8 | 4 | 3 | 1 | 0 | 5 | 7 | 1 | 1 | 0 | .296 | .481 | .394 | .875 |